Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fatty liver, hypertension, and the metabolic syndrome.

Literature DB >> 15194635

Fatty liver, hypertension, and the metabolic syndrome.

Abstract

The prevalence of fatty liver in non-obese non-diabetic hypertensive patients is at least twice that of the general population and may be related to increases in insulin resistance and body weight.

Entities: Disease Gene Species

Mesh：

Year: 2004 PMID： 15194635 PMCID： PMC1774127 DOI： 10.1136/gut.2003.037309

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

30 in total

Review 1. beta-Agonists and metabolism.

Authors: L H Philipson
Journal: J Allergy Clin Immunol Date: 2002-12 Impact factor: 10.793

2. Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors: S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal: Ann Intern Med Date: 2000-01-18 Impact factor: 25.391

Review 3. Clinical features and natural history of nonalcoholic steatosis syndromes.

Authors: Y Falck-Ytter; Z M Younossi; G Marchesini; A J McCullough
Journal: Semin Liver Dis Date: 2001 Impact factor: 6.115

4. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Authors: L E Adinolfi; M Gambardella; A Andreana; M F Tripodi ; R Utili; G Ruggiero
Journal: Hepatology Date: 2001-06 Impact factor: 17.425

5. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors: C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal: Gastroenterology Date: 1999-06 Impact factor: 22.682

6. Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis.

Authors: A Nonomura; Y Mizukami; M Unoura; K Kobayashi; Y Takeda; R Takeda
Journal: Gastroenterol Jpn Date: 1992-08

7. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.

Authors: E E Powell; W G Cooksley; R Hanson; J Searle; J W Halliday; L W Powell
Journal: Hepatology Date: 1990-01 Impact factor: 17.425

Review 8. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia.

Authors: V Large; P Arner
Journal: Diabetes Metab Date: 1998-11 Impact factor: 6.041

9. Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury.

Authors: L Van Waes; C S Lieber
Journal: Gastroenterology Date: 1977-10 Impact factor: 22.682

10. The natural history of nonalcoholic fatty liver: a follow-up study.

Authors: M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal: Hepatology Date: 1995-12 Impact factor: 17.425

19 in total

1. A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease.

Authors: Sandhya Mishra; Dharamveer Yadav; Monika Gupta; Hemant Mishra; Praveen Sharma
Journal: Indian J Clin Biochem Date: 2012-12-29

2. Malabaricone C as Natural Sphingomyelin Synthase Inhibitor against Diet-Induced Obesity and Its Lipid Metabolism in Mice.

Authors: Muhamad Aqmal Othman; Kohei Yuyama; Yuta Murai; Yasuyuki Igarashi; Daisuke Mikami; Yasodha Sivasothy; Khalijah Awang; Kenji Monde
Journal: ACS Med Chem Lett Date: 2019-07-03 Impact factor: 4.345

3. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

Authors: Ariel E Feldstein; Nathan W Werneburg; Zhengzheng Li; Steven F Bronk; Gregory J Gores
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2006-02-16 Impact factor: 4.052

4. Hyperinsulinemia predisposes to NAFLD.

Authors: Sandhya Mishra; Dharamveer Yadav; Monika Gupta; Hemant Mishra; Praveen Sharma
Journal: Indian J Clin Biochem Date: 2008-06-11

5. PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome.

Authors: Hong Chen; Abul Fajol; Miriam Hoene; Bingbing Zhang; Erwin D Schleicher; Yun Lin; Carsten Calaminus; Bernd J Pichler; Cora Weigert; Hans U Häring; Florian Lang; Michael Föller
Journal: Proc Natl Acad Sci U S A Date: 2016-05-02 Impact factor: 11.205

Review 6. Liver diseases and metabolic syndrome.

Authors: Sumio Watanabe; Reiko Yaginuma; Kenichi Ikejima; Akihisa Miyazaki
Journal: J Gastroenterol Date: 2008-07-23 Impact factor: 7.527

7. Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats.

Authors: Yongzhong Wei; Suzanne E Clark; John P Thyfault; Grace M E Uptergrove; Wenhan Li; Adam T Whaley-Connell; Carlos M Ferrario; James R Sowers; Jamal A Ibdah
Journal: Am J Pathol Date: 2009-02-26 Impact factor: 4.307

8. Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis.

Authors: Eugen Florin Georgescu; Reanina Ionescu; Mihaela Niculescu; Laurentiu Mogoanta; Liliana Vancica
Journal: World J Gastroenterol Date: 2009-02-28 Impact factor: 5.742

9. RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome.

Authors: Jyotsana Singhal; Lokesh Nagaprashantha; Rit Vatsyayan; Sanjay Awasthi; Sharad S Singhal
Journal: PLoS One Date: 2011-09-13 Impact factor: 3.240

Review 10. Exercise in the metabolic syndrome.

Authors: Saeid Golbidi; Azam Mesdaghinia; Ismail Laher
Journal: Oxid Med Cell Longev Date: 2012-07-05 Impact factor: 6.543